Cargando…
Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rate
OBJECTIVES: The averted infections ratio (AIR) is a novel measure for quantifying the preservation-of-effect in active-control non-inferiority clinical trials with a time-to-event outcome. In the main formulation, the AIR requires an estimate of the counterfactual placebo incidence rate. We describe...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
De Gruyter
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204757/ https://www.ncbi.nlm.nih.gov/pubmed/35880996 http://dx.doi.org/10.1515/scid-2021-0002 |